BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34888236)

  • 1. Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell Lymphomas.
    Sethi S; Epstein-Peterson Z; Kumar A; Ho C
    Front Oncol; 2021; 11():739441. PubMed ID: 34888236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.
    Nadeu F; Martin-Garcia D; Clot G; Díaz-Navarro A; Duran-Ferrer M; Navarro A; Vilarrasa-Blasi R; Kulis M; Royo R; Gutiérrez-Abril J; Valdés-Mas R; López C; Chapaprieta V; Puiggros M; Castellano G; Costa D; Aymerich M; Jares P; Espinet B; Muntañola A; Ribera-Cortada I; Siebert R; Colomer D; Torrents D; Gine E; López-Guillermo A; Küppers R; Martin-Subero JI; Puente XS; Beà S; Campo E
    Blood; 2020 Sep; 136(12):1419-1432. PubMed ID: 32584970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.
    Clot G; Jares P; Giné E; Navarro A; Royo C; Pinyol M; Martín-Garcia D; Demajo S; Espinet B; Salar A; Ferrer A; Muntañola A; Aymerich M; Rauert-Wunderlich H; Jaffe ES; Connors JM; Gascoyne RD; Delabie J; López-Guillermo A; Ott G; Wright GW; Staudt LM; Rosenwald A; Scott DW; Rimsza LM; Beà S; Campo E
    Blood; 2018 Jul; 132(4):413-422. PubMed ID: 29769262
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
    Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus.
    Shiller SM; Zieske A; Holmes H; Feldman AL; Law ME; Saad R
    Cancer Genet; 2011 Mar; 204(3):162-4. PubMed ID: 21504716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variant t(2;11)(p11.2;q13) without IGK involvement in a case of mantle cell lymphoma.
    Woroniecka R; Grygalewicz B; Pienkowska-Grela B; Rymkiewicz G; Konecki R; Swoboda P; Janik P
    Cancer Genet Cytogenet; 2007 Jun; 175(2):154-8. PubMed ID: 17556072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare case of t(11;22) in a mantle cell lymphoma like B-cell neoplasia resulting in a fusion of IGL and CCND1: case report.
    Rocha CK; Praulich I; Gehrke I; Hallek M; Kreuzer KA
    Mol Cytogenet; 2011 Apr; 4(1):8. PubMed ID: 21457541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and Clinical Determinants Shaping Heterogeneity in Mantle Cell Lymphoma.
    López C; Silkenstedt E; Dreyling M; Beà S
    Blood Adv; 2024 May; ():. PubMed ID: 38748869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.
    Salaverria I; Royo C; Carvajal-Cuenca A; Clot G; Navarro A; Valera A; Song JY; Woroniecka R; Rymkiewicz G; Klapper W; Hartmann EM; Sujobert P; Wlodarska I; Ferry JA; Gaulard P; Ott G; Rosenwald A; Lopez-Guillermo A; Quintanilla-Martinez L; Harris NL; Jaffe ES; Siebert R; Campo E; Beà S
    Blood; 2013 Feb; 121(8):1394-402. PubMed ID: 23255553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
    Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W
    Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathologic diagnosis of mantle cell lymphoma.
    Li S; Xu J; You MJ
    Histol Histopathol; 2021 Oct; 36(10):1037-1051. PubMed ID: 34114641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Presentation of Hairy Cell Leukemia and Mantle Cell Lymphoma (Leukemic Non-Nodal Variant): An Extremely Rare Composite Lymphoma.
    Soliman DS; Ibrahim F; Fernyhough LJ; Murad F; Akiki S
    J Hematol; 2022 Feb; 11(1):21-28. PubMed ID: 35356636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
    Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wnt signaling pathway and mitotic regulators in the initiation and evolution of mantle cell lymphoma: Gene expression analysis.
    Kimura Y; Arakawa F; Kiyasu J; Miyoshi H; Yoshida M; Ichikawa A; Niino D; Sugita Y; Okamura T; Doi A; Yasuda K; Tashiro K; Kuhara S; Ohshima K
    Int J Oncol; 2013 Aug; 43(2):457-68. PubMed ID: 23760751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of detecting immunoglobulin gene rearrangements in the diagnosis of B-cell lymphoma.
    Lu C; He Q; Zhu W; Fu C; Zhou J; Tao Y; Liu S; Xiao D
    Oncotarget; 2017 Sep; 8(44):77009-77019. PubMed ID: 29100365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma.
    Remstein ED; Kurtin PJ; Buño I; Bailey RJ; Proffitt J; Wyatt WA; Hanson CA; Dewald GW
    Br J Haematol; 2000 Sep; 110(4):856-62. PubMed ID: 11054068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
    Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
    Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complex landscape of genetic alterations in mantle cell lymphoma.
    Royo C; Salaverria I; Hartmann EM; Rosenwald A; Campo E; Beà S
    Semin Cancer Biol; 2011 Nov; 21(5):322-34. PubMed ID: 21945515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.
    Beà S; Amador V
    Curr Oncol Rep; 2017 Jun; 19(6):43. PubMed ID: 28466437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant somatic hypermutation of CCND1 generates non-coding drivers of mantle cell lymphomagenesis.
    Müller H; Walter W; Hutter S; Nadarajah N; Meggendorfer M; Kern W; Haferlach T; Haferlach C
    Cancer Gene Ther; 2022 May; 29(5):484-493. PubMed ID: 35145272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.